Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MALAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM175A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGPS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JPX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BICD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ICA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASEK-C17orf49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NOTCH2NL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACOT13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASEL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBKS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP7D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on